Chairman's AGM Statement

| Filed in:

At the Annual General Meeting of Tate & Lyle PLC to be held in London today, Sir David Lees, Chairman, will make the following statement on current trading and expansion projects:

“Trading has started strongly in the current financial year. The first quarter’s results were well ahead of those in the corresponding period, excluding the benefit of reduced depreciation (£25 million on an annual basis) arising from the impairment charge of £272 million taken last year. This was due mainly to a continuation of the strong performance from Food & Industrial Ingredients Americas and from sugar trading.

Work on our appropriate response to the changes in the EU Sugar Regime continues.

Across the business we have a number of expansion projects under way which will stimulate longer term growth in our value added segment.

Both of the expansions at the McIntosh, Alabama SPLENDA® Sucralose facility have been completed on time. The first of these is now operating at capacity and the second is in a commissioning period that we expect to last for several months. Construction of the new SPLENDA® Sucralose facility in Singapore remains on schedule for mechanical completion in January 2007. The increased production capacity from these investments will enable us to build further the customer base and SPLENDA® Sucralose brand. We have specifically designed the Singapore plant with the potential for its capacity to be doubled, if required.

Our new joint venture plant with DuPont to produce Bio-PDOTM from renewable resources has also been completed on schedule and is being commissioned. This is a unique plant, the first in the world to produce Bio-PDO, and we expect that commissioning and production ramp up will take some time to complete. We remain excited about the longer term market for Bio-PDO which has potential in markets as diverse as apparel, carpets, automotive and electronics.

Our other US expansion projects in Sagamore and Loudon and the recently announced investment in a new corn-wet mill in Fort Dodge, Iowa continue to progress satisfactorily.

Total investment in these three projects will be some £250 million. This reflects our firm commitment to deliver against our growth strategy and in particular to grow the contribution from value added products.

We continue to view the future with confidence and remain committed to our target for the profit contribution from total value added products to increase by 30% in the year to March 2007 from the £161 million reported last year.”

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube